Miscellaneous ocular agents:

Indications for OXERVATE:

Neurotrophic keratitis.

Adults and Children:

<2yrs: not established. ≥2yrs: 1 drop in the affected eye(s) 6 times daily (at 2hr intervals) for 8 weeks.


Contact lenses (remove; may reinsert lenses 15mins after administration). Pregnancy. Nursing mothers.

Pharmacologic Class:

Recombinant human nerve growth factor.


Allow at least 15mins between application of other topical oph agents. Administer Oxervate 15mins prior to using eye ointment, gel or other viscous eye drops.

Adverse Reactions:

Eye pain, corneal deposits, foreign body sensation, ocular hyperemia, eye inflammation, increased lacrimation.

Generic Availability:


How Supplied:

Multiple-dose vials—7 (w. Delivery System Kit)

Pricing for OXERVATE

7 vials of 20mcg/ml carton (Qty: 4)
Appx. price $49478